Last 47 quarters of trend data · Healthcare · Medical - Healthcare Information Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -5.38 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.44 | 0.63 | 0.40 | 0.48 | 0.54 | 0.61 | 0.55 | 0.61 | 0.61 | 0.65 | 0.98 | 1.35 | 1.16 | 1.59 | 1.68 | 1.50 | 1.68 | 2.26 | 5.12 | 6.62 | 9.69 |
| — | +3.8% | -27.8% | -21.7% | -11.8% | -6.4% | -43.8% | -54.7% | -47.1% | -59.3% | -41.5% | -9.9% | -30.7% | -29.6% | -67.3% | -77.3% | -82.7% | -82.5% | -66.4% | -60.4% | -38.9% | |
| P/B Ratio | 0.78 | 1.17 | 0.73 | 0.89 | 0.98 | 1.08 | 0.97 | 1.05 | 1.04 | 1.11 | 1.11 | 1.54 | 1.34 | 1.81 | 1.84 | 1.66 | 0.68 | 0.88 | 1.27 | 0.92 | 1.26 |
| — | +8.2% | -24.8% | -15.5% | -6.6% | -2.8% | -12.2% | -31.5% | -22.0% | -38.8% | -39.9% | -7.4% | +97.5% | +105.6% | +45.4% | +81.6% | -46.4% | -45.7% | -27.5% | -43.3% | -84.6% | |
| P/FCF | 3.88 | 5.99 | 31.07 | 3.62 | 5.00 | 4.25 | — | 6.98 | 4.98 | 4.80 | 81.48 | 6.95 | 11.29 | 10.47 | 97.74 | 16.15 | 17.32 | 14.90 | — | 45.73 | 67.05 |
| — | +41.0% | — | -48.1% | +0.3% | -11.4% | — | +0.4% | -55.9% | -54.2% | -16.6% | -57.0% | -34.8% | -29.7% | — | -64.7% | -74.2% | -88.5% | — | — | -66.5% | |
| EV / EBITDA | 13.63 | — | 6.95 | 8.52 | — | — | — | 81.14 | 51.30 | — | — | 26.30 | 130.63 | — | — | — | — | — | — | — | — |
| — | — | — | -89.5% | — | — | — | +208.6% | -60.7% | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.5% | 102.5% | 52.8% | 69.3% | 70.1% | 69.8% | 68.7% | 70.5% | 71.9% | 70.7% | 69.9% | 70.7% | 71.8% | 70.8% | 69.8% | 70.4% | 69.6% | 69.2% | 66.9% | 68.4% | 67.6% |
| — | +46.7% | -23.2% | -1.7% | -2.5% | -1.2% | -1.7% | -0.3% | +0.1% | -0.1% | +0.1% | +0.5% | +3.2% | +2.3% | +4.3% | +2.9% | +3.0% | +1.5% | -1.3% | +0.7% | +6.0% | |
| Operating Margin | -10.4% | -6.1% | -7.9% | -5.6% | -8.3% | -8.6% | -19.2% | -7.5% | -6.9% | -130.9% | -13.5% | -5.3% | -9.8% | -11.0% | -12.3% | -598.3% | -11.7% | -522.7% | -1179.7% | -7.5% | -11.6% |
| — | +29.0% | +58.6% | +25.5% | -19.7% | +93.4% | -42.1% | -41.7% | +29.3% | -1092.3% | -10.0% | +99.1% | +16.4% | +97.9% | +99.0% | -7904.3% | -1.0% | -3231.4% | -6220.4% | +93.8% | -70.0% | |
| Net Margin | -7.9% | -6.4% | -10.4% | -3.9% | -7.9% | -5.2% | -14.8% | -7.6% | -5.2% | -130.4% | -12.7% | -4.4% | -8.6% | -10.0% | -11.0% | -597.5% | -12.0% | -523.6% | -1180.6% | -2.0% | -16.2% |
| — | -24.0% | +29.6% | +48.2% | -52.1% | +96.0% | -16.6% | -72.8% | +39.9% | -1205.1% | -15.2% | +99.3% | +28.1% | +98.1% | +99.1% | -30044.4% | +25.7% | -1868.5% | -2582.7% | +98.1% | -30.1% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -13.9% | -2.9% | -4.7% | -1.8% | -3.5% | -2.3% | -6.4% | -3.2% | -2.2% | -44.2% | -3.5% | -1.3% | -2.5% | -2.8% | -3.0% | -91.1% | -1.2% | -40.7% | -53.0% | -0.1% | -0.5% |
| — | -28.3% | +26.4% | +43.9% | -59.1% | +94.8% | -79.6% | -158.2% | +11.1% | -1454.9% | -17.9% | +98.6% | -105.4% | +93.0% | +94.3% | -132765.3% | -129.6% | -4744.9% | -4109.1% | +98.4% | +74.1% | |
| ROA | -6.1% | -1.4% | -2.2% | -0.8% | -1.7% | -1.0% | -2.7% | -1.4% | -0.9% | -21.4% | -1.9% | -0.7% | -1.3% | -1.5% | -1.5% | -59.5% | -0.9% | -32.3% | -46.3% | -0.1% | -0.5% |
| — | -35.7% | +19.1% | +38.8% | -81.8% | +95.2% | -42.2% | -107.4% | +28.5% | -1313.2% | -22.3% | +98.9% | -45.6% | +95.3% | +96.7% | -95728.5% | -89.6% | -4149.2% | -3998.0% | +98.3% | +60.9% | |
| ROIC | -11.5% | -1.7% | -2.2% | -1.6% | -2.2% | -2.3% | -5.0% | -2.0% | -1.8% | -26.8% | -2.3% | -0.9% | -1.7% | -1.8% | -1.9% | -58.9% | -0.8% | -27.8% | -38.0% | -0.2% | -0.3% |
| — | +23.0% | +55.5% | +19.2% | -27.0% | +91.5% | -114.6% | -113.6% | -4.7% | -1373.2% | -20.9% | +98.4% | -111.7% | +93.5% | +94.9% | -31061.2% | -188.2% | -7658.0% | -9814.6% | +94.9% | +72.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.75 | 0.78 | 0.78 | 0.75 | 0.75 | 0.73 | 1.11 | 1.06 | 1.05 | 1.06 | 0.69 | 0.68 | 0.69 | 0.69 | 0.69 | 0.69 | 0.26 | 0.26 | 0.17 | 0.08 | 0.08 |
| — | +7.6% | -30.1% | -29.4% | -29.0% | -31.2% | +60.0% | +55.2% | +52.7% | +53.1% | +0.4% | -0.5% | +162.9% | +164.2% | +298.8% | +761.9% | +225.4% | +228.5% | +95.5% | -14.2% | -81.8% | |
| Debt / EBITDA | 10.38 | — | 22.84 | 23.76 | — | — | — | 276.98 | 169.86 | — | — | 41.38 | 228.36 | — | — | — | — | — | — | — | — |
| — | — | — | -91.4% | — | — | — | +569.3% | -25.6% | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.69 | 0.83 | 2.80 | 2.69 | 2.70 | 2.67 | 1.68 | 1.77 | 1.73 | 1.62 | 3.73 | 3.54 | 3.44 | 3.45 | 3.37 | 3.22 | 3.13 | 3.38 | 3.94 | 3.70 | 3.83 |
| — | -68.9% | +66.3% | +52.0% | +56.2% | +64.5% | -55.0% | -50.1% | -49.9% | -52.9% | +10.7% | +10.1% | +10.1% | +1.8% | -14.3% | -13.1% | -18.3% | -15.4% | -0.7% | +16.2% | -41.3% | |
| Quick Ratio | 2.59 | 0.81 | 2.72 | 2.59 | 2.60 | 2.58 | 1.64 | 1.73 | 1.69 | 1.59 | 3.65 | 3.47 | 3.36 | 3.36 | 3.25 | 3.07 | 2.99 | 3.22 | 3.71 | 3.48 | 3.64 |
| — | -68.6% | +65.6% | +50.1% | +54.0% | +62.4% | -55.0% | -50.2% | -49.7% | -52.7% | +12.2% | +12.9% | +12.4% | +4.2% | -12.3% | -11.7% | -18.0% | -15.1% | -0.9% | +15.4% | -43.7% | |
| Interest Coverage | -10.95 | -5.94 | -10.33 | -5.79 | -10.10 | -10.29 | -9.53 | -6.16 | -7.13 | -8.71 | -13.64 | -5.40 | -10.36 | -10.12 | -11.98 | — | -10.81 | -11.45 | -11.84 | -1.95 | -2.98 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying TDOC stock.
Teladoc Health, Inc.'s current P/E is -5.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Teladoc Health, Inc.'s current operating margin is -10.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Teladoc Health, Inc.'s business trajectory between earnings reports.